skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Good morning, I am looking for an alternative to big American tech. Hopefully in Europe or perhaps Asia. When large Canadian pension plans are moving away from US investments, I think this is worth exploring. Would appreciate your thoughts.
Read Answer Asked by Joanne on April 17, 2025
Q: Hi,

I hold VXUS and have decided I'd like to instead concentrate my international holdings on four stocks: ASML, LVMUY, MDLZ and NVS. I was wondering, recognizing you don't cover European companies, are there any obvious red flags with these four companies. I know there is no comparison between and ETF and individual stocks. Sector is not a concern.

Thank you. Michael
Read Answer Asked by Michael on October 27, 2023
Q: I own nvs and thinking of swapping it with an health global ETF. Is there one on the US side similar to the global can hedged XHC?
appreciate your opinion
thanks a lot
margit
Read Answer Asked by margit on July 30, 2020
Q: I’ve patiently held GUD for 4 years now without it doing much. Could you recommend 1 or 2 replacements from the Healthcare sector in the U.S. ?

I don’t understand the healthcare business myself, so I’m looking for a company with solid management that I can invest in, and then just forget about it for years to come.
Read Answer Asked by Andrew on June 04, 2020
Q: Healthcare is approximately 10% of our portfolio. Medical Facilities is the largest investment which we have held for a long time. JNJ and HCP we have added more recently. NVS and AZN we inherited. We want to simplify our portfolio and plan to sell NVS and AZN and add to JNJ. Wonder what your opinion is of DR and HCP specifically and also AZN which I didn't see mentioned in your question section.
Thank you, Marie
Read Answer Asked by J on July 06, 2018
Q: I have held Novartis for a few years and still show a profit of ~33%. However it has dropped significantly in the last 18 months. In the pharma space, I also hold Knight Therapeutic (GUD) and Johnson & Johnson (JNJ). I wonder if Novartis is still worth keeping or should I consider switching to something else (or increasing my holding in J&J or GUD). It represents ~1% of my portfolio which is well diversified but light on pharma. Although not your primary field of expertise, I would still appreciate any light you could shed on the company. Thank you for your valuable insights.
Read Answer Asked by jacques on November 18, 2016
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!